⌘K

Home/Filings/4/0001213900-21-001426

4//SEC Filing

GLASSPOOL JOHN 4

Accession 0001213900-21-001426

CIK 0001553643other

View on SEC.gov Company Profile

Filed

Jan 10, 7:00 PM ET

Accepted

Jan 11, 4:09 PM ET

Size

5.3 KB

Accession

0001213900-21-001426

Insider Transaction Report

Form 4

Period: 2021-01-07

RELMADA THERAPEUTICS, INC.RLMD

Director

Transactions

Award
Options to purchase common stock
2021-01-07+100,000→ 100,000 total
Exercise: $33.43From: 2021-04-07Exp: 2031-01-07→ Common Stock (100,000 underlying)

Footnotes (1)

[F1]The options vest from the date of grant in quarterly increments of 6.25%.

Documents

1 file

4
ownership.xmlPrimary

Issuer

RELMADA THERAPEUTICS, INC.

CIK 0001553643

Entity typeother

Related Parties

1

filerCIK 0001644079

Filing Metadata

Form type: 4
Filed: Jan 10, 7:00 PM ET
Accepted: Jan 11, 4:09 PM ET
Size: 5.3 KB

View on SEC.gov